FDA-cleared ADHD diagnostic platform for clinics and remote care
Qbtech operates a regulated medical-device business in ADHD diagnostics, running a multi-cloud infrastructure (AWS, GCP, Azure) with a data platform built on Iceberg and AWS Glue. The hiring mix tilts heavily toward sales (7 roles) and management (7 total), with engineering (3) and healthcare operations (2) supporting them—a pattern consistent with a clinician-facing SaaS in market expansion. Active projects reveal dual operational tracks: scaling clinical workflows and infrastructure (cloud governance, data ingestion) while driving adoption through regional sales and customer success.
Qbtech develops QbCheck, an FDA and MDR-cleared online objective ADHD assessment tool for patients aged 6–60, designed for use in clinical settings or remotely. The platform is marketed to clinicians and clinics as a diagnostic and treatment-monitoring aid, supported by clinical advisors who handle customer onboarding and training. The company is privately held, founded in 2002, and operates from Stockholm with a current headcount between 51 and 200. Revenue-generating operations span multiple countries: active hiring occurs in the United States, United Kingdom, Sweden, and the Netherlands.
Qbtech's stack includes AWS (primary cloud), Iceberg and AWS Glue for data processing, Python and Java for application code, Ktor for backend services, and Salesforce for customer relationship management. The company also uses GCP and Azure, indicating a multi-cloud approach.
Qbtech is actively recruiting in the United States, United Kingdom, Sweden, and the Netherlands. Most open roles are sales, management, and healthcare operations positions.
Other companies in the same industry, closest in size